XBiotech Inc.XBITNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average, modest growth trend.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-247.22%
↑ 79% above average
Average (39q)
-1195.21%
Historical baseline
Range
High:12753.33%
Low:-59900.00%
CAGR
+8.0%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | -247.22% |
| Q2 2025 | 84.00% |
| Q1 2025 | -5.88% |
| Q4 2024 | -112.50% |
| Q3 2024 | 62.79% |
| Q2 2024 | -30.30% |
| Q1 2024 | -120.00% |
| Q4 2023 | 37.50% |
| Q3 2023 | 17.24% |
| Q2 2023 | -123.08% |
| Q1 2023 | -18.18% |
| Q4 2022 | 73.81% |
| Q3 2022 | -10.53% |
| Q2 2022 | -111.11% |
| Q1 2022 | 14.29% |
| Q4 2021 | -90.91% |
| Q3 2021 | 35.29% |
| Q2 2021 | -94.73% |
| Q1 2021 | -39.01% |
| Q4 2020 | 27.82% |
| Q3 2020 | 63.75% |
| Q2 2020 | -59900.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | 12753.33% |
| Q3 2019 | 6.25% |
| Q2 2019 | 0.00% |
| Q1 2019 | 5.88% |
| Q4 2018 | -21.43% |
| Q3 2018 | 12.50% |
| Q2 2018 | -45.45% |
| Q1 2018 | 45.00% |
| Q4 2017 | -11.11% |
| Q4 2017 | 30.77% |
| Q2 2017 | 18.75% |
| Q1 2017 | 36.00% |
| Q4 2016 | -31.58% |
| Q3 2016 | 9.52% |
| Q2 2016 | -31.25% |
| Q1 2016 | 13.51% |
| Q4 2015 | -12.12% |